1. Home
  2. IMAB vs CVGI Comparison

IMAB vs CVGI Comparison

Compare IMAB & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • CVGI
  • Stock Information
  • Founded
  • IMAB 2014
  • CVGI 2000
  • Country
  • IMAB United States
  • CVGI United States
  • Employees
  • IMAB N/A
  • CVGI N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • CVGI Auto Parts:O.E.M.
  • Sector
  • IMAB Health Care
  • CVGI Consumer Discretionary
  • Exchange
  • IMAB Nasdaq
  • CVGI Nasdaq
  • Market Cap
  • IMAB 73.9M
  • CVGI 71.8M
  • IPO Year
  • IMAB 2020
  • CVGI 2004
  • Fundamental
  • Price
  • IMAB $0.89
  • CVGI $1.13
  • Analyst Decision
  • IMAB Strong Buy
  • CVGI Buy
  • Analyst Count
  • IMAB 2
  • CVGI 1
  • Target Price
  • IMAB $5.50
  • CVGI N/A
  • AVG Volume (30 Days)
  • IMAB 220.3K
  • CVGI 415.8K
  • Earning Date
  • IMAB 04-03-2025
  • CVGI 05-06-2025
  • Dividend Yield
  • IMAB N/A
  • CVGI N/A
  • EPS Growth
  • IMAB N/A
  • CVGI N/A
  • EPS
  • IMAB N/A
  • CVGI N/A
  • Revenue
  • IMAB N/A
  • CVGI $723,355,000.00
  • Revenue This Year
  • IMAB N/A
  • CVGI N/A
  • Revenue Next Year
  • IMAB N/A
  • CVGI $6.33
  • P/E Ratio
  • IMAB N/A
  • CVGI N/A
  • Revenue Growth
  • IMAB N/A
  • CVGI N/A
  • 52 Week Low
  • IMAB $0.60
  • CVGI $0.81
  • 52 Week High
  • IMAB $2.00
  • CVGI $6.31
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 54.14
  • CVGI 52.18
  • Support Level
  • IMAB $0.85
  • CVGI $0.88
  • Resistance Level
  • IMAB $0.97
  • CVGI $1.12
  • Average True Range (ATR)
  • IMAB 0.06
  • CVGI 0.10
  • MACD
  • IMAB 0.01
  • CVGI 0.04
  • Stochastic Oscillator
  • IMAB 56.71
  • CVGI 91.94

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a supplier of cab-related products and systems. Its operating segments are Vehicle Solutions, Industrial Automation, Electrical Systems, and Aftermarket and Accessories. Vehicle Solutions segment designs manufacture and sell Commercial vehicle seats and Plastic components. Warehouse Automation segment designs, manufactures, and sells Warehouse automation subsystems including control panels, electro-mechanical assemblies, cable assemblies, and power and communication solutions. Electrical Systems segment designs, manufactures and sells cable and harness assemblies for both high and low voltage applications, control boxes, dashboard assemblies, and design and engineering for these applications. The company makes majority of its revenue from Vehicle Solutions.

Share on Social Networks: